Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Proteomics of prostate cancer cell lines

ABSTRACT: We profiled the proteomics of prostate cancer (PCa) cell lines.

ORGANISM(S): Homo Sapiens Mus Musculus

SUBMITTER: Zongren Wang

PROVIDER: PXD058635 | iProX | Fri Dec 06 00:00:00 GMT 2024

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Publications

Integrated proteogenomic characterization of localized prostate cancer identifies biological insights and subtype-specific therapeutic strategies.

Ou Wei W Zhang Xin-Xin XX Li Bin B Tuo Ying Y Lin Ren-Xuan RX Liu Peng-Fei PF Guo Jian-Ping JP Un Hio-Cheng HC Li Ming-Hao MH Lei Jia-Hao JH Gao Xiao-Jing XJ Zheng Fu-Fu FF Chen Ling-Wu LW Long Ling-Li LL Wang Zong-Ren ZR

Nature communications 20250403 1

Localized prostate cancer (PCa) is highly variable in their response to therapies. Although a fraction of this heterogeneity can be explained by clinical factors or genomic and transcriptomic profiling, the proteomic-based profiling of aggressive PCa remains poorly understood. Here, we profiled the genome, transcriptome, proteome and phosphoproteome of 145 cases of localized PCa in Chinese patients. Proteome-based stratification of localized PCa revealed three subtypes with distinct molecular fe ...[more]

PMID: 40180929

Similar Datasets

RNA-seq analysis of isogenic mouse prostate cancer cell lines with distinct sensitivity to immune checkpoint therapy

Project description:Resistant to immune checkpoint blockade (ICB) therapy, especially in a few solid tumor types including advanced prostate cancer (PCa), represents a formidable clinical challenge. In this study, we developed a series of ICB-resistant PCa cell lines from an ICB-sensitive PCa cell line previously developed from the PB-Cre+ PtenL/L p53L/L Smad4L/L mouse model of metastatic PCa. These four cell lines were profiled with RNAseq.

2024-02-13 | GSE252986 | GEO

Proteomics profiles of prostate cancer cell lines

Project description:Prostate cancer (PCa) is a major public health issue in industrialized countries, mainly because of patients’ relapse by castration-refractory disease after androgen ablation. PCa progresses through a series of clinical states characterized by the extent of the disease, the hormonal status (castration-sensitive or castration-resistant) and the presence or absence of metastases. Progression to castration-resistant prostate cancer (CRPCa) involves several mechanisms such as ligand-independent androgen receptor activation and adaptive up-regulation of anti-apoptotic genes. CRPCa is highly aggressive and incurable, jeopardizing the patient’s quality of life and lifespan. Identifying the molecular events responsible for the progression to CRPCa is essential to avoid its development and design specific therapies. Despite the existing treatment guidelines for PCa and novel clinical trials for CRPCa, major challenges still remain for identifying specific CRPCa biomarkers and therapeutic targets for effective tailored therapy design for these patients. In this context, molecular profiling of human PCa may importantly contribute to the identification of new disease-specific biomarkers in order to improve PCa early diagnosis, prognosis and disease course and to predict strategies that help develop novel therapies. System-wide approaches such as transcriptomics and proteomics are nowadays applied to monitor molecular variations at the cellular level. Proteomics approaches offer a great potential for the discovery of novel biomarkers and the identification of new therapeutic agents by accurate quantification of proteins. Several studies have been published in the past where different proteomics approaches were used to identify PCa proteome. In the present study we analyzed the PCa proteome from several PCa cell lines representing different hormonal status of the disease to identify potential biomarkers differentially expressed in CRPCa.

2020-01-14 | PXD004970 | Pride

Phosphoproteome profiles of prostate cancer cell lines

2020-01-14 | PXD004992 | Pride

Profiles of prostate cancer cell lines

Project description:Profiles of prostate cancer cell lines

| PRJNA343724 | ENA

Expression profiling of prostate cell lines by miRNA array

Project description:Prostate cancer (PCa) is the most common malignant carcinoma that develops in men in Western countries. Up to 30% of patients continue to suffer from disease progression following radical prostatectomy. Therefore, better prognostic markers and molecular targets for cancer treatment are needed. MicroRNA (miRNA) has the potential to be used as biomarkers and as a therapeutic target for the treatment of various cancers, including PCa. Here, to determine how miRNA is involved in PCa progression, we investigated the miRNA expression profiles of 3 PCa cell lines, namely PC3, DU145, and LNCaP, and 2 normal prostate cell lines, namely RWPE-1 and PrSc, using miRNA microarrays. We investigated miRNA genes that were significantly upregulated in PCa cell lines (PC3, DU145, LNCaP) compared with normal cell lines (RWPE-1, PrSc).

2013-09-01 | E-GEOD-40026 | biostudies-arrayexpress

Proteomic characterization of Prostate cancer cell lines

Project description:Proteomic characterization of prostate cancer cell lines after drug treatment.

2022-10-13 | PXD029525 | Pride

Expression profiling of prostate cell lines by miRNA array

2013-09-01 | GSE40026 | GEO

CDK2 knockdown in prostate cancer cell lines

Project description:CDK2 knockdown in prostate cancer cell lines

| PRJNA1190430 | ENA

Arginine effect on prostate cancer cell lines

Project description:Arginine effect on prostate cancer cell lines

| PRJNA628669 | ENA